Pharmaceutical IP and competition law in Finland: Overview

Thomson Reuters’ Practical Law Life Sciences Global Guide 2021

Posted on

22 Mar

2021

Dittmar & Indrenius > Insight > Pharmaceutical IP and competition law in Finland: Overview

A Q&A guide to pharmaceutical IP and competition law in Finland.

The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports. The Q&A is part of the Thomson Reuters’ Global Guide to Life Sciences law.

Read the Finland chapter we contributed.

Written by

Johan Åkermarck

Partner

Share this